Vistin Pharma (VISTIN)

TekBot · mai 28, 2020, 6:22am

Vistin Pharma ASA - flaggemelding

TekBot · mai 28, 2020, 2:48pm

Disclosure of large shareholding and mandatory notification of trade in Vistin Pharma ASA

TekBot · mai 29, 2020, 1:30pm

Vistin Pharma ASA: Independent Auditor’s Report for 2019

Please find attached the Independent Auditor’s Report for 2019 for Vistin Pharma
ASA. The whole set of documents in relation to the 2019 annual report is
available on www.vistin.com (http://www.vistin.com).
…
Vis børsmeldingen
                                 *****
For further information, please contact:

Alexander Karlsen
CFO
+47 97 05 36 21
Alexander.karlsen@vistin.com

Kilde

TekBot · juni 3, 2020, 7:49am

Mandatory notification of trade

TekBot · juni 3, 2020, 11:46am

Vistin Pharma ASA : Call for Extraordinary General Meeting

Oslo, Norway, 03 June 2020

Vistin Pharma ASA (OSE: VISTIN), please find attached the call for an
…

Vis børsmeldingen

Extraordinary General Meeting in Vistin Pharma, to be held on 24 June at 13:00
CEST. Due to the Covid-19 situation, the Extraordinary General Meeting will be
held as a digital meeting. Information with guide for online participation will
be shared in well advance of the general meeting.

Following changes in the ownership of Vistin Pharma ASA, more specifically
Intertrade Shipping AS now being the largest shareholder with 24.2%, the
Election Committee has received input from new shareholders regarding the
composition of the Board. Intertrade has proposed that Øivin A Brøymer and Kari
Krogstad are elected as new board members replacing Ole Enger and Mimi K.
Berdal. The proposal from the election committee is attached.

The formal call will be sent to all shareholders registered in the Norwegian
Central Security Depository (VPS). The complete set of documents relating to the
Extraordinary General Meeting are also attached to this announcement and
available on www.vistin.com.

For further information, please contact:

Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com (mailto:alexander.karlsen@vistin.com)

This information is subject to the disclosure requirements pursuant to
section 5-12 of the Norwegian Securities Trading Act.

Kilde

TekBot · juni 15, 2020, 2:42pm

Mandatory notification of trade in Vistin Pharma ASA

TekBot · juni 17, 2020, 6:18am

Vistin Pharma ASA: Guide for online participation at EGM

Oslo, Norway, 17 June 2020

Vistin Pharma ASA (OSE: VISTIN), as previously announced Vistin Pharma ASA will
…

Vis børsmeldingen

be conducting the Extraordinary General Meeting on the 24 of June as a digital
meeting, through Skype. This is a precautionary measure to prevent the spread of
Covid-19 and to ensure the safety and wellbeing of our shareholders, employees
and other stakeholders. Therefore, there will be no opportunity for physical
presence. You may cast votes prior to the meeting or grant a proxy. Please refer
the notice for the EGM and appendices for further information on voting in
advance and proxies. Attached is a stepwise guide for how to attend the meeting.

The complete set of documents relating to the Extraordinary General Meeting are
available on www.vistin.com.

For further information, please contact:

Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com (mailto:alexander.karlsen@vistin.com)

This information is subject to the disclosure requirements pursuant to
section 5-12 of the Norwegian Securities Trading Act.

Kilde

TekBot · juni 24, 2020, 12:08pm

Vistin Pharma ASA: Minutes from the extraordinary general meeting

TekBot · juli 14, 2020, 1:40pm

Meldepliktig avslutning av aksjekjøp på termin i Vistin Pharma ASA

TekBot · august 21, 2020, 9:03am

Vistin Pharma ASA: Invitation to second quarter and first half results conference call

Oslo, Norway, 21 August 2020

Vistin Pharma ASA will release its second quarter and first half 2020 results on
…
Vis børsmeldingen

Friday 28 August 2020. Vistin Pharma will host a conference call for all
shareholders and interested parties on Friday 28 August at 08:30 CEST. There
will be a Q&A session following the management discussion.

The conference call will be held in Norwegian.

The second quarter conference call will be available via web and audio through
the following access points:

Telephone conference:
Confirmation Code:… 9358318
International Dial-In:… +44 (0) 2071 928338
Norway, Oslo:… +47 21563015
United States, New York: +1 6467413167

Webcast:
https://edge.media-server.com/mmc/p/b48bigg6
                                 *****
For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com

Kilde

TekBot · august 28, 2020, 5:34am

Vistin Pharma ASA: Second quarter and first half 2020 financial results

Oslo, Norway, 28 August 2020

Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial
…
Vis børsmeldingen

results for the second quarter and first half of 2020, with a 20% increase in
revenue and EBITDA of MNOK 20.9 for the pharmaceutical business in Q2 - highest
revenue and EBITDA ever in a quarter. For first half 2020 revenue increased by
30% and EBITDA by 200% versus first half 2019.

The revenues for the second quarter of 2020 ended at MNOK 73 (Q2’19: MNOK
61.1). For first half of 2020 the revenue was MNOK 134.4, compared to MNOK
103.3 in first half of 2019, a growth of 30%.

Second quarter EBITDA for pharmaceuticals was MNOK 20.9 (Q1’19: MNOK13.3), and a
first half 2020 EBITDA of MNOK 35.1, compared to MNOK 11.7 in first half of
2019.

The net profit for the group ended at MNOK 20.7 (Q2’19: MNOK 0.4) for the second
quarter of 2020. For first half 2020 the net loss was MNOK 110.1, compared to
profit of MNOK 2.4 in first half of 2019, driven by the loss of closing the oil
derivative portfolio in March.

Vistin Pharma had cash of MNOK 109 (Q2’19 MNOK: 290.7) as of 30 June 2020, and a
strong balance sheet with an equity ratio of 83%. Dividend of NOK 1 per share
was paid to shareholders in June.

The second quarter conference call, which will be held today, 28 August, at
8.30am (CEST) and will be available via web and audio through the following
access points:

Telephone conference:
Confirmation Code:… 9358318
International Dial-In:… +44 (0) 2071 928338
Norway, Oslo:… +47 21563015
United States, New York: +1 6467413167

Webcast:
https://edge.media-server.com/mmc/p/b48bigg6

The conference call will be held in Norwegian.

Please find the Q2 and first half 2020 report and presentation enclosed. The
report will also be made available on www.vistin.com (http://www.vistin.com).
                                 *****
For further information, please contact:

Kjell-Erik Nordby
CEO
+47 91 36 42 80
kjell-erik.nordby@vistin.com (mailto:kjell-erik.nordby@vistin.com)

Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com (mailto:alexander.karlsen@vistin.com)

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

Kilde

TekBot · august 28, 2020, 5:34am

Vistin Pharma ASA: Second quarter and first half 2020 financial results

Oslo, Norway, 28 August 2020

Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial
…
Vis børsmeldingen

results for the second quarter and first half of 2020, with a 20% increase in
revenue and EBITDA of MNOK 20.9 for the pharmaceutical business in Q2 - highest
revenue and EBITDA ever in a quarter. For first half 2020 revenue increased by
30% and EBITDA by 200% versus first half 2019.

The revenues for the second quarter of 2020 ended at MNOK 73 (Q2’19: MNOK
61.1). For first half of 2020 the revenue was MNOK 134.4, compared to MNOK
103.3 in first half of 2019, a growth of 30%.

Second quarter EBITDA for pharmaceuticals was MNOK 20.9 (Q1’19: MNOK13.3), and a
first half 2020 EBITDA of MNOK 35.1, compared to MNOK 11.7 in first half of
2019.

The net profit for the group ended at MNOK 20.7 (Q2’19: MNOK 0.4) for the second
quarter of 2020. For first half 2020 the net loss was MNOK 110.1, compared to
profit of MNOK 2.4 in first half of 2019, driven by the loss of closing the oil
derivative portfolio in March.

Vistin Pharma had cash of MNOK 109 (Q2’19 MNOK: 290.7) as of 30 June 2020, and a
strong balance sheet with an equity ratio of 83%. Dividend of NOK 1 per share
was paid to shareholders in June.

The second quarter conference call, which will be held today, 28 August, at
8.30am (CEST) and will be available via web and audio through the following
access points:

Telephone conference:
Confirmation Code:… 9358318
International Dial-In:… +44 (0) 2071 928338
Norway, Oslo:… +47 21563015
United States, New York: +1 6467413167

Webcast:
https://edge.media-server.com/mmc/p/b48bigg6

The conference call will be held in Norwegian.

Please find the Q2 and first half 2020 report and presentation enclosed. The
report will also be made available on www.vistin.com (http://www.vistin.com).
                                 *****
For further information, please contact:

Kjell-Erik Nordby
CEO
+47 91 36 42 80
kjell-erik.nordby@vistin.com (mailto:kjell-erik.nordby@vistin.com)

Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com (mailto:alexander.karlsen@vistin.com)

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

Kilde

TekBot · august 28, 2020, 3:04pm

Vistin Pharma ASA: Mandatory notification of trade

Kjell_Makrell · august 28, 2020, 9:22pm

It wasn’t me

Kjell_Makrell · august 31, 2020, 9:45am

CEO solgte for å bygge hytte. Det er det som har kommet frem

Ekspertis1 · september 3, 2020, 11:27am

Ser veldig bra ut teknisk her nå. 20-tallet er nok ikke langt unna

Quadruple · september 3, 2020, 12:23pm

Hvor har du det fra? Om det stemmer er det fryktelig klønete. Han kunne lånt penger til byggingen til bare noen få prosenters rente som han kunne dekket med kursoppgangen som kommer. Hvis han har tro på kursoppgang da? Og det er jo nettopp det som er så negativt når primærinsidere selger. Det signaliserer at de ikke har forventninger til nevneverdig verdiøkning den nærmeste tiden.

rayman · september 3, 2020, 12:27pm

Den har gått mye opp, det er aldri feil å sikre grevinst i dagens marked.

Kjell_Makrell · september 3, 2020, 12:32pm

Jeg kjenner noen på gulvet i Vistin. Kun dem jeg siterer. Ja det er klønete, men noen mennesker ønsker seg ikke mere penger.

Ekspertis1 · september 14, 2020, 10:07am

Motstanden på 19,15 brutt tidligere i dag. Ser veldig bra ut! Fortjener en langt høyere prising enn i dag. Tydeligvis fler enn meg som skjønner det